This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Global Collagen And HA-Based Biomaterials Industry

7. CORPORATE ACTIVITY IN THE RECENT PAST - A PERSPECTIVE BUILDER II-39Getinge AB Merges with Datascope Corp II-39Human Biosciences GmbH Sets Up New Facility in Luckenwalde, Germany II-39TiGenix Takes Over Orthomimetics II-39Integra LifeSciences Inks Licensing Deal with Organogenesis II-39Abbott Takes Over Advanced Medical Optics II-40Anika Signs Exclusive Distribution Agreement with CoaptSystems II-40Rousselot Takes Over PEPTAN II-41Alynx Takes Over MiMedx II-41Covidien Acquires Tissue Science Laboratories II-41Warburg Pincus Takes Over Lifecore Biomedical II-41

8. FOCUS ON SELECT KEY PLAYERS II-42 ABBOTT (US) II-42Alcon Laboratories, Inc. (US) II-42Allergan, Inc. (US) II-43Anika Therapeutics, Inc. (US) II-43Bausch & Lomb, Inc. (US) II-44Lifecore Biomedical, LLC (US) II-44Q-Med AB ( Sweden) II-45Sanofi SA ( France) II-45Genzyme (US) II-46Seikagaku Corp. ( Japan) II-46Teijin Pharma Limited ( Japan) II-47

9. GLOBAL MARKET PERSPECTIVE II-48Table 4: World Recent Past, Current & Future Analysis forCollagen and HA-Based Biomaterials by Geographic Region - US, Canada, Japan, Europe and Rest of World Markets IndependentlyAnalyzed with Annual Sales Figures in US$ Million for Years2010 through 2018 (includes corresponding Graph/Chart) II-48

Table 5: World Historic Review for Collagen and HA-BasedBiomaterials by Geographic Region - US, Canada, Japan, Europe,and Rest of World Markets Independently Analyzed with AnnualSales Figures in US$ Million for Years 2004 through 2009(includes corresponding Graph/Chart) II-49

Table 6: World 15-Year Perspective for Collagen and HA-BasedBiomaterials by Geographic Region - Percentage Breakdown ofDollar Sales for US, Canada, Japan, Europe and Rest of WorldMarkets for Years 2004, 2012 & 2018 (includes correspondingGraph/Chart) II-50Collagen and HA-Based Biomaterials Market by Product Group/Segment II-51Collagen-based Biomaterials Market by Region II-51Table 7: World Recent Past, Current & Future Analysis forCollagen Based Biomaterials by Geographic Region - US, Canada, Japan, Europe, and Rest of World MarketsIndependently Analyzed with Annual Sales Figures in US$Million for Years 2010 through 2018 (includes correspondingGraph/Chart) II-51

Table 8: World Historic Review for Collagen BasedBiomaterials by Geographic Region - US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzedwith Annual Sales Figures in US$ Million for Years 2004through 2009 (includes corresponding Graph/Chart) II-52

Table 9: World 15-Year Perspective for Collagen BasedBiomaterials by Geographic Region - Percentage Breakdown ofDollar Sales for US, Canada, Japan, Europe, and Rest ofWorld Markets for Years 2004, 2012 & 2018 (includescorresponding Graph/Chart) II-53Collagen Based Biomaterials Market by Product Segment II-54Table 10: World Recent Past, Current & Future Analysis forCollagen-based Biomaterials by Product Segment - UrinaryIncontinence Products, Corneal Shields, Facial AestheticDermal Fillers, and Wound Dressings Markets IndependentlyAnalyzed with Annual Sales Figures in US$ Million for Years2010 through 2018 (includes corresponding Graph/Chart) II-54

Table 11: World Historic Review for Collagen-basedBiomaterials by Product Segment - Urinary IncontinenceProducts, Corneal Shields, Facial Aesthetic Dermal Fillers,and Wound Dressings Markets Independently Analyzed withAnnual Sales Figures in US$ Million for Years 2004 through2009 (includes corresponding Graph/Chart) II-55

3 of 12

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,098.74 -73.94 -0.43%
S&P 500 1,988.37 -5.92 -0.30%
NASDAQ 4,524.7220 -2.9670 -0.07%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs